Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam + Alfentanil vs Ciprofol + Alfentanil for Sedation During Fiberoptic Bronchoscopy
ChiCTR2500104535Phase 4Not yet recruiting
- Sponsor
- Xiangya Hospital, Central South University
- Start
- Jun 2025
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in procedural pain and anxiety disorder comparing Remimazolam + Alfentanil with Ciprofol + Alfentanil (2 arms). Primary endpoints: Anesthesia induction success rate, Incidence of intraoperative hypotension and 1 more. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
remimazolamciprofolalfentanil
03
Conditions
procedural painanxiety disorder
Beyond the preview
Go deeper on ChiCTR2500104535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104535.